Covaxin Shows 77.8 % Efficacy In Phase 3 Trial: SEC
New Delhi: The Subject Expert Committee (SEC) under the drug regulator on Tuesday said that Hyderabad based Bharat Biotech's Covaxin has shown 77.8 per cent efficacy.
According to reports, the company had submitted data from the Phase…